Of the 2 patients treated for breast cancer, one trans man had a history of gender-affirming bilateral mastectomy and was later diagnosed with metastatic ER positive, PR weakly positive, HER2 negative breast cancer. This evidence concerns the gene ERBB2 and breast carcinoma.